About James Robl
James Robl is a co-founder, president and CSO, director at Immuno Cancer Biotherapeutics.
Experience
This experience comes from SEC filings. The years are when the filings name James Robl in the role, so the role may have started earlier or lasted longer.
Immuno Cancer Biotherapeutics, Inc.
Co-founder, President and CSO, director
2026 · Canton, SD
Develops antibody-based therapies intended to treat cancer.
Key Colleagues at Startups
The people James Robl works with at each company, as listed on that company's latest Form D.
Immuno Cancer Biotherapeutics, Inc. · Form D, Oct 15, 2026
SC
Stephen Collins
Director